GU CONNECT has summarised the highlights from ESMO 2018 for you.
GU oncology by Dr. Fabio Schutz, Beneficencia Portuguesa de Sao Paulo, Brazil
GU CONNECT has summarised the highlights from ESMO 2018 for you.
GU oncology by Dr. Fabio Schutz, Beneficencia Portuguesa de Sao Paulo, Brazil
Dr Fabio Schutz graduated from Parana Federal University and did his internal medicine residency at Hospital de Clinicas in Curitiba - PR, Brazil. Then, he moved to São Paulo - SP for his medical oncology clinical fellowship at Hospital Sirio Libanes. After finishing his medical oncology fellowship, he worked for a couple of years as an assistant medical oncologist in the same hospital. From 2009 to 2011, he worked as a research fellow in genitourinary (GU) oncology in the Lank Center for GU Oncology at the Dana-Farber Cancer Institute - Harvard Medical School in Boston - MA, USA. He developed several original research projects and authored many manuscripts in high-impact journals. Since mid-2011, he is working as a medical oncologist of the BP - Beneficencia Portuguesa de Sao Paulo in Sao Paulo - SP, Brazil. He is most interested and is currently conducting clinical trials in GU cancers.
Astellas, Bayer, BMS, Janssen and Ipsen
Recommendations for best practice
Paper published in Journal of Gastrointestinal Cancer
Get your free professional profile photos taken with us at Booth 507
Maximising outcomes for patients with advanced neuroendocrine tumours
Clinical application of liquid biopsy, and how it applies to NSCLC, breast and colorectal cancer
Maximising outcomes for patients with advanced RCC